Neochem Bio Solutions
Neochem Bio Solutions (NEOCHEM) share price was ₹104.70 at the 28 Oct 2026 close; market capitalisation ₹179 Cr; sector Chemicals. In the Mar 2026 quarter, revenue was ₹65 Cr, against ₹47 Cr a year earlier and net profit was ₹7 Cr, against ₹6 Cr a year earlier (compared with Mar 2025). Promoters held 66.88% of Neochem Bio Solutions in Sep 2026, up 0.16 percentage points from Mar 2026. Its Tapetide Score is 60/100 (Good) as of 28 Oct 2026.
Key Fundamentals
SMEChemicals & PetrochemicalsChemicalsPrice-based figures as of 29 Oct 2026, 10:10 IST · TTM
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,368.30 | 52.59 | 1,39,276 Cr | 12.87 | 1.48% | 22.36% | 28.48% | 15,689 Cr | 2,677 Cr | |
| ₹4,248.20 | 77.13 | 46,666 Cr | 5.97 | 0.07% | 7.25% | 10.13% | 5,334 Cr | 600 Cr | |
| ₹8,359.50 | 54.26 | 42,878 Cr | 10.79 | 0.18% | 16.70% | 18.66% | 3,734 Cr | 789 Cr | |
| ₹1,578.80 | 89.05 | 20,955 Cr | 8.53 | 0.00% | 8.94% | 12.15% | 1,257 Cr | 235 Cr | |
| ₹1,486.40 | 25.88 | 20,273 Cr | 3.47 | 0.52% | 9.38% | 10.85% | 8,624 Cr | 784 Cr | |
| ₹460.75 | 31.47 | 16,707 Cr | 2.81 | 0.23% | 7.04% | 8.53% | 9,040 Cr | 531 Cr | |
| ₹5,155.00 | 19.66 | 15,177 Cr | 2.31 | 0.55% | 10.95% | 13.54% | 7,185 Cr | 788 Cr | |
| Neochem Bio Solutions (this company) | ₹104.00 | — | 178 Cr | 2.26 | 0.00% | 39.24% | 39.40% | — | — |
| Median 8 companies | ₹1,532.60 | 52.59 | 20,614 Cr | 4.72 | 0.21% | 10.17% | 12.85% | 7,185 Cr | 784 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 81/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 28.8%
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 161 days.
- Working capital days have increased from 77.8 days to 164 days
Technical Indicators
Oscillators
Neutral
Overall
Bullish
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 17% · Mar 2026
Quarterly Results
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 47 | 65 |
| Expenses | 39 | 54 |
| Operating Profit | 8 | 11 |
| OPM % | 17% | 17% |
| Other Income | 2 | 1 |
| Interest | 2 | 2 |
| Depreciation | 1 | 1 |
| PBT | 7 | 10 |
| Tax % | 24% | 30% |
| Net Profit | 6 | 7 |
| EPS (₹) | 8.31 | 4.01 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 49 | 48 | 61 | 84 | 111 |
| Expenses | 45 | 44 | 55 | 71 | 91 |
| Operating Profit | 4 | 4 | 6 | 13 | 20 |
| OPM % | 7% | 9% | 10% | 15% | 18% |
| Other Income | 0 | 1 | 1 | 2 | 2 |
| Interest | 1 | 2 | 3 | 4 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 |
| PBT | 1 | 2 | 3 | 10 | 17 |
| Tax % | 25% | 28% | 31% | 25% | 30% |
| Net Profit | 1 | 1 | 2 | 7 | 12 |
| EPS (₹) | 3.23 | 2.1 | 2.89 | 11.15 | 7.03 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 3 | 5 | 7 | 7 | 17 |
| Reserves | 1 | 3 | 6 | 13 | 62 |
| Borrowings | 23 | 26 | 33 | 36 | 18 |
| Other Liabilities | 19 | 16 | 18 | 24 | 20 |
| Total Liabilities | 46 | 51 | 63 | 79 | 117 |
| Fixed Assets | 12 | 15 | 19 | 19 | 20 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 6 |
| Other Assets | 34 | 36 | 45 | 60 | 91 |
| Total Assets | 46 | 51 | 63 | 79 | 117 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | -1 | -1 | -1 | 2 | -17 |
| Investing | -3 | -3 | 12 | -1 | -9 |
| Financing | 4 | 4 | -11 | -1 | 26 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -4 | -4 | 11 | 1 | -19 |
| CFO/OP | -36 | -23 | -10 | 23 | -70 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 102 | 107 | 100 | 110 | 161 |
| Inventory Days | 141 | 173 | 172 | 157 | 143 |
| Days Payable | 186 | 155 | 142 | 111 | 56 |
| Cash Conversion Cycle | 58 | 125 | 131 | 156 | 247 |
| Working Capital Days | 17 | 19 | 30 | 39 | 164 |
| ROCE % | — | 12% | 14% | 26% | 28% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Neochem Bio Solutions insights
55 extracted metrics + investor summaries across FY22–FY26.
Documents
Frequently Asked Questions about Neochem Bio Solutions
What does Neochem Bio Solutions Ltd do?
Where is Neochem Bio Solutions Ltd (NEOCHEM) listed?
Which sector does Neochem Bio Solutions Ltd belong to?
What is the market capitalisation of Neochem Bio Solutions Ltd?
What is the 52-week high and low of Neochem Bio Solutions Ltd?
What is the Return on Equity (ROE) of Neochem Bio Solutions Ltd?
Company Information
Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/NEOCHEM.md for Neochem Bio Solutions Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.